ArticleHormones (Athens, Greece)2026
Hand pathology in type 1 diabetes mellitus: a case-control study.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to investigate the factors associated with diabetic hand (DH) in patients with type 1 diabetes mellitus (T1D) using a matched case-control design.
methodsA retrospective case-control study was conducted at a tertiary care hospital in Spain. Among a cohort of 968 T1D patients, 45 cases of DH were identified. Cases were matched with 90 controls using propensity score matching based on age, sex, diabetes duration, and presence of retinopathy. Clinical data, comorbidities, and glycemic control (HbA1c and continuous glucose monitoring metrics) were collected. Multivariable conditional logistic regression was used to identify factors associated with DH.
resultsDH prevalence was 4.6%. Significant associations were found for HbA1c (OR 1.96; 95% CI 1.16-3.28; p = 0.011) and age (OR 1.06; 95% CI 1.01-1.12; p = 0.012). Cardiovascular disease was more common in DH cases (20.2% vs. 2.2%; p = 0.005), but it was not independently associated after adjustment. No significant differences were observed for retinopathy, nephropathy, or other microvascular complications.
conclusionsChronic poor glycemic control, indicated by higher HbA1c, is strongly associated with DH. These findings suggest that DH is a distinct complication of T1D, driven more by hyperglycemia than traditional vascular risk factors. Further research is needed to elucidate pathophysiological mechanisms and therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.